Cargando…

The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?

The maintained attention is the cause of great functional limitations in CFS/ME, a disease that mainly affects women in the central period of life. Cognitive function is explored using the Montreal Cognitive Assessment, the maintained attention using the Toulouse-Piéron test with which the Global In...

Descripción completa

Detalles Bibliográficos
Autores principales: Murga, Iñigo, Aranburu, Larraitz, Gargiulo, Pascual A., Gómez-Esteban, Juan-Carlos, Lafuente, José-Vicente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645147/
https://www.ncbi.nlm.nih.gov/pubmed/34863209
http://dx.doi.org/10.1186/s12967-021-03153-1
_version_ 1784610248121647104
author Murga, Iñigo
Aranburu, Larraitz
Gargiulo, Pascual A.
Gómez-Esteban, Juan-Carlos
Lafuente, José-Vicente
author_facet Murga, Iñigo
Aranburu, Larraitz
Gargiulo, Pascual A.
Gómez-Esteban, Juan-Carlos
Lafuente, José-Vicente
author_sort Murga, Iñigo
collection PubMed
description The maintained attention is the cause of great functional limitations in CFS/ME, a disease that mainly affects women in the central period of life. Cognitive function is explored using the Montreal Cognitive Assessment, the maintained attention using the Toulouse-Piéron test with which the Global Index of Attention and Perception (GIAP) is obtained, the fatigue using the visual analog scale and the perception of effort using the modified Borg scale. The final sample were 84 patients (66 women/18 men) who met diagnostic criteria (Fukuda-1994, Carruthers-2011) and 22 healthy controls (14 women/8 men). Most of patients maintain normal cognitive function, showing low or very low attention score in the 70% of patients with a marked cognitive fatigue compared to the control group (p < 0.05). There were no significant differences between genders in GIAP or fatigue for CFS/ME; however, sick women perceive cognitive effort higher than men. Deficits in sustained attention and the perception of fatigue, so effort after performing the proposed test are a sensitive and reliable indicator that allows us to substantiate a clinical suspicion and refer patients for further studies in order to confirm or rule out CFS/ME.
format Online
Article
Text
id pubmed-8645147
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86451472021-12-06 The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker? Murga, Iñigo Aranburu, Larraitz Gargiulo, Pascual A. Gómez-Esteban, Juan-Carlos Lafuente, José-Vicente J Transl Med Research The maintained attention is the cause of great functional limitations in CFS/ME, a disease that mainly affects women in the central period of life. Cognitive function is explored using the Montreal Cognitive Assessment, the maintained attention using the Toulouse-Piéron test with which the Global Index of Attention and Perception (GIAP) is obtained, the fatigue using the visual analog scale and the perception of effort using the modified Borg scale. The final sample were 84 patients (66 women/18 men) who met diagnostic criteria (Fukuda-1994, Carruthers-2011) and 22 healthy controls (14 women/8 men). Most of patients maintain normal cognitive function, showing low or very low attention score in the 70% of patients with a marked cognitive fatigue compared to the control group (p < 0.05). There were no significant differences between genders in GIAP or fatigue for CFS/ME; however, sick women perceive cognitive effort higher than men. Deficits in sustained attention and the perception of fatigue, so effort after performing the proposed test are a sensitive and reliable indicator that allows us to substantiate a clinical suspicion and refer patients for further studies in order to confirm or rule out CFS/ME. BioMed Central 2021-12-04 /pmc/articles/PMC8645147/ /pubmed/34863209 http://dx.doi.org/10.1186/s12967-021-03153-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Murga, Iñigo
Aranburu, Larraitz
Gargiulo, Pascual A.
Gómez-Esteban, Juan-Carlos
Lafuente, José-Vicente
The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?
title The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?
title_full The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?
title_fullStr The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?
title_full_unstemmed The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?
title_short The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?
title_sort maintained attention assessment in patients affected by myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645147/
https://www.ncbi.nlm.nih.gov/pubmed/34863209
http://dx.doi.org/10.1186/s12967-021-03153-1
work_keys_str_mv AT murgainigo themaintainedattentionassessmentinpatientsaffectedbymyalgicencephalomyelitischronicfatiguesyndromeareliablebiomarker
AT aranburularraitz themaintainedattentionassessmentinpatientsaffectedbymyalgicencephalomyelitischronicfatiguesyndromeareliablebiomarker
AT gargiulopascuala themaintainedattentionassessmentinpatientsaffectedbymyalgicencephalomyelitischronicfatiguesyndromeareliablebiomarker
AT gomezestebanjuancarlos themaintainedattentionassessmentinpatientsaffectedbymyalgicencephalomyelitischronicfatiguesyndromeareliablebiomarker
AT lafuentejosevicente themaintainedattentionassessmentinpatientsaffectedbymyalgicencephalomyelitischronicfatiguesyndromeareliablebiomarker
AT murgainigo maintainedattentionassessmentinpatientsaffectedbymyalgicencephalomyelitischronicfatiguesyndromeareliablebiomarker
AT aranburularraitz maintainedattentionassessmentinpatientsaffectedbymyalgicencephalomyelitischronicfatiguesyndromeareliablebiomarker
AT gargiulopascuala maintainedattentionassessmentinpatientsaffectedbymyalgicencephalomyelitischronicfatiguesyndromeareliablebiomarker
AT gomezestebanjuancarlos maintainedattentionassessmentinpatientsaffectedbymyalgicencephalomyelitischronicfatiguesyndromeareliablebiomarker
AT lafuentejosevicente maintainedattentionassessmentinpatientsaffectedbymyalgicencephalomyelitischronicfatiguesyndromeareliablebiomarker